Centene completes acquisition of PANTHERx Rare Pharmacy
ST. LOUIS — Centene Corp. has completed its acquisition of PANTHERx, one of the largest and fastest-growing specialty pharmacies in the United States specializing in orphan drugs and treating rare diseases. “We are pleased to welcome the PANTHERx team to the Centene family,” said Michael F. Neidorff, chairman, president and chief executive officer for Centene. “PANTHERx is a